• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Crohn's disease

AbbVie Beyond a Gut Feeling Tyler James Williams
Marketing

AbbVie taps Tyler James Williams for new IBD campaign

AbbVie is going back to school to support patients with IBD, enrolling “Abbott Elementary” star Tyler James Williams for a new campaign.
Andrea Park Oct 7, 2025 2:12pm
Digestion digestive system stomach ibd crohns disease ulcerative colitis

J&J's Tremfya picks up key FDA nod in Crohn's disease

Mar 20, 2025 7:56pm
Lilly

Lilly's Omvoh bests J&J's Stelara in Crohn's study

Oct 14, 2024 12:15pm
Tremfya

Subcutaneous version of J&J's Tremfya excels in Crohn's trial

Jun 20, 2024 11:12am
Tremfya

UPDATED: J&J readies Tremfya for IBD showdown with AbbVie, Lilly

May 21, 2024 9:49am
Eli Lilly

Lilly pads case for mirikizumab in its next potential indication

May 21, 2024 9:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings